Our findings show that the inhibition of microglial proliferation in a model of Alzheimer’s disease-like pathology does not modify the burden of amyloid-β plaques, suggesting an uncoupling of the amyloidogenic process from the pathological progression of the disease. Here, PPIB is linked to Alzheimer disease.